Summary
Regeneron Pharmaceuticals, Inc. (REGN) filed an 8-K on November 13, 2015, to report a change in its Board of Directors. Robert A. Ingram resigned from his position as a Director and member of the Compensation Committee, effective November 10, 2015. The company stated that Mr. Ingram's resignation was due to demands from his other business activities and not a result of any disagreement with Regeneron's operations, policies, or practices.
Key Highlights
- 1Robert A. Ingram has resigned from Regeneron's Board of Directors.
- 2Mr. Ingram also resigned from the Compensation Committee of the Board.
- 3The resignation was effective November 10, 2015.
- 4The reason cited for resignation is increased demands from other business activities.
- 5Regeneron stated there were no disagreements with Mr. Ingram regarding the company's operations, policies, or practices.